My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 194

    1.

    Antiviral therapy for adults with chronic hepatitis B: a systematic review for a National Institutes of Health Consensus Development Conference.

    Shamliyan TA, MacDonald R, Shaukat A, Taylor BC, Yuan JM, Johnson JR, Tacklind J, Rutks I, Kane RL, Wilt TJ.

    Ann Intern Med. 2009 Jan 20;150(2):111-24. Epub 2009 Jan 5. Review.PMID: 19124812 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Management of chronic hepatitis B.

    Wilt TJ, Shamliyan T, Shaukat A, Taylor BC, MacDonald R, Yuan JM, Johnson JR, Tacklind J, Rutks I, Kane RL.

    Evid Rep Technol Assess (Full Rep). 2008 Oct;(174):1-671. Review.PMID: 19408969 [PubMed - indexed for MEDLINE]Related articles

    3.

    Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.

    Shepherd J, Jones J, Takeda A, Davidson P, Price A.

    Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. Review.PMID: 16904047 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    NIH consensus development statement on management of hepatitis B.

    [No authors listed]

    NIH Consens State Sci Statements. 2008 Oct 22-24;25(2):1-29.PMID: 18949020 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Treatment of chronic hepatitis B: case selection and duration of therapy.

    Leung N.

    J Gastroenterol Hepatol. 2002 Apr;17(4):409-14. Review.PMID: 11982721 [PubMed - indexed for MEDLINE]Related articles

    6.

    Management of viral hepatitis B.

    Pramoolsinsup C.

    J Gastroenterol Hepatol. 2002 Feb;17 Suppl:S125-45. Review.PMID: 12000599 [PubMed - indexed for MEDLINE]Related articles

    7.

    A randomized, controlled trial of combination therapy for chronic hepatitis B: comparing pegylated interferon-alpha2b and lamivudine with lamivudine alone.

    Chan HL, Leung NW, Hui AY, Wong VW, Liew CT, Chim AM, Chan FK, Hung LC, Lee YT, Tam JS, Lam CW, Sung JJ.

    Ann Intern Med. 2005 Feb 15;142(4):240-50.PMID: 15710957 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Evaluation of the cost-effectiveness of entecavir versus lamivudine in hepatitis BeAg-positive chronic hepatitis B patients.

    Yuan Y, Iloeje UH, Hay J, Saab S.

    J Manag Care Pharm. 2008 Jan-Feb;14(1):21-33.PMID: 18240879 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Comparison of antiviral effect of lamivudine with interferon-alpha2a versus -alpha2b in children with chronic hepatitis B infection.

    Ozgenc F, Dikici B, Targan S, Doganci T, Akman S, Aydogdu S, Yagci RV.

    Antivir Ther. 2004 Feb;9(1):23-6.PMID: 15040533 [PubMed - indexed for MEDLINE]Related articles

    10.

    Entecavir: a new nucleoside analogue for the treatment of chronic hepatitis B.

    Rivkin A.

    Drugs Today (Barc). 2007 Apr;43(4):201-20. Review.PMID: 17460784 [PubMed - indexed for MEDLINE]Related articles

    11.

    2-Year GLOBE trial results: telbivudine Is superior to lamivudine in patients with chronic hepatitis B.

    Liaw YF, Gane E, Leung N, Zeuzem S, Wang Y, Lai CL, Heathcote EJ, Manns M, Bzowej N, Niu J, Han SH, Hwang SG, Cakaloglu Y, Tong MJ, Papatheodoridis G, Chen Y, Brown NA, Albanis E, Galil K, Naoumov NV; GLOBE Study Group.

    Gastroenterology. 2009 Feb;136(2):486-95. Epub 2008 Nov 1.PMID: 19027013 [PubMed - indexed for MEDLINE]Related articles

    12.

    Cross-study analysis of the relative efficacies of oral antiviral therapies for chronic hepatitis B infection in nucleoside-naive patients.

    Dienstag JL, Wei LJ, Xu D, Kreter B.

    Clin Drug Investig. 2007;27(1):35-49. Review.PMID: 17177578 [PubMed - indexed for MEDLINE]Related articles

    13.

    NIH Consensus Statement on Management of Hepatitis C: 2002.

    [No authors listed]

    NIH Consens State Sci Statements. 2002 Jun 10-12;19(3):1-46. Review.PMID: 14768714 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Treatment alternatives for chronic hepatitis B virus infection: a cost-effectiveness analysis.

    Kanwal F, Gralnek IM, Martin P, Dulai GS, Farid M, Spiegel BM.

    Ann Intern Med. 2005 May 17;142(10):821-31.PMID: 15897532 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Management of patients with chronic hepatitis B.

    Liaw YF.

    J Gastroenterol Hepatol. 2002 Apr;17(4):406-8. Review.PMID: 11982720 [PubMed - indexed for MEDLINE]Related articles

    16.

    Treatment of chronic hepatitis B virus infection - Dutch national guidelines.

    Buster EH, van Erpecum KJ, Schalm SW, Zaaijer HL, Brouwer JT, Gelderblom HC, de Knegt RJ, Minke Bakker C, Reesink HW, Janssen HL; Netherlands Association of Gastroenterologists and Hepatologists.

    Neth J Med. 2008 Jul-Aug;66(7):292-306. Review.PMID: 18663260 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Natural course, therapeutic options and economic evaluation of therapies for chronic hepatitis B.

    Han SH.

    Drugs. 2006;66(14):1831-51. Review.PMID: 17040114 [PubMed - indexed for MEDLINE]Related articles

    18.

    [Effect of interferon-alpha treatment in children with hepatitis B e antigen-positive chronic hepatitis B virus infection: a meta-analysis of follow-up for six months to two years]

    Lin ZQ, Fang F, Guo ZF, Chen Q.

    Zhonghua Er Ke Za Zhi. 2007 Aug;45(8):592-8. Chinese. PMID: 18021533 [PubMed - in process]Related articles

    19.

    Sequential combination of glucocorticosteroids and alfa interferon versus alfa interferon alone for HBeAg-positive chronic hepatitis B.

    Mellerup MT, Krogsgaard K, Mathurin P, Gluud C, Poynard T.

    Cochrane Database Syst Rev. 2005 Jul 20;(3):CD000345. Review.PMID: 16034852 [PubMed - indexed for MEDLINE]Related articles

    20.

    Sequential combination of glucocorticosteroids and alfa interferon versus alfa interferon alone for HBeAg-positive chronic hepatitis B.

    Mellerup MT, Krogsgaard K, Mathurin P, Gluud C, Poynard T.

    Cochrane Database Syst Rev. 2002;(2):CD000345. Review. Update in: Cochrane Database Syst Rev. 2005;(3):CD000345. PMID: 12076393 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity